Total Payments
$1,035
2024 Payments
$385.85
Companies
13
Transactions
40
Medicare Patients
19,476
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$877.36 (84.7%)
Education$157.98 (15.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $877.36 | 38 | 84.7% |
| Education | $157.98 | 2 | 15.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $239.02 | 7 | $0 (2024) |
| Incyte Corporation | $235.65 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $156.06 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.85 | 6 | $0 (2024) |
| Genentech USA, Inc. | $116.47 | 1 | $0 (2019) |
| Adaptive Biotechnologies Corporation | $43.40 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $24.65 | 1 | $0 (2022) |
| SOBI, INC | $20.64 | 1 | $0 (2023) |
| Eisai Inc. | $17.51 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.72 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $385.85 | 14 | Daiichi Sankyo Inc. ($239.02) |
| 2023 | $445.52 | 20 | Incyte Corporation ($215.65) |
| 2022 | $62.59 | 3 | Janssen Biotech, Inc. ($24.65) |
| 2021 | $13.74 | 1 | AstraZeneca Pharmaceuticals LP ($13.74) |
| 2019 | $127.64 | 2 | Genentech USA, Inc. ($116.47) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Oncology | ||||||
| 04/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/28/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/22/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.35 | General |
| Category: Hematology/Oncology | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Hematology/Oncology | ||||||
| 09/22/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: Hematology/Oncology | ||||||
| 09/22/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $2.38 | General |
| Category: Hematology/Oncology | ||||||
| 09/20/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 753 | 1,385 | $220,405 | $38,329 |
| 2022 | 13 | 3,276 | 7,852 | $796,019 | $165,037 |
| 2021 | 8 | 8,450 | 23,616 | $1.6M | $485,365 |
| 2020 | 7 | 6,997 | 21,423 | $1.5M | $510,046 |
Total Patients
19,476
Total Services
54,276
Medicare Billing
$1.2M
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 223 | 363 | $90,387 | $10,466 | 11.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 86 | 388 | $41,904 | $8,536 | 20.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 57 | 91 | $25,480 | $5,754 | 22.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 146 | 186 | $20,088 | $5,029 | 25.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 31 | 57 | $12,255 | $1,844 | 15.0% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 16 | 31 | $5,857 | $1,685 | 28.8% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 21 | 41 | $4,428 | $1,218 | 27.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 58 | 74 | $3,256 | $723.60 | 22.2% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 12 | 15 | $3,435 | $723.60 | 21.1% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 36 | 40 | $3,280 | $699.24 | 21.3% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 16 | 24 | $2,330 | $661.82 | 28.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 11 | 27 | $1,944 | $558.01 | 28.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 40 | 48 | $5,760 | $431.45 | 7.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 869 | 3,197 | $327,256 | $64,347 | 19.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 874 | 1,609 | $160,518 | $44,933 | 28.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Office | 2022 | 862 | 1,588 | $91,768 | $15,743 | 17.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 100 | 577 | $62,270 | $12,868 | 20.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 189 | 318 | $79,065 | $9,278 | 11.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 142 | 193 | $20,876 | $5,305 | 25.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 45 | 74 | $20,731 | $4,803 | 23.2% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 11 | 32 | $6,046 | $1,796 | 29.7% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2022 | 26 | 48 | $5,212 | $1,448 | 27.8% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2022 | 51 | 64 | $5,248 | $1,148 | 21.9% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2022 | 12 | 29 | $2,816 | $810.77 | 28.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 12 | 15 | $3,435 | $738.24 | 21.5% |
About Dr. Daniel Sanchez, M.D
Dr. Daniel Sanchez, M.D is a General Practice healthcare provider based in South Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1508278532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Sanchez, M.D has received a total of $1,035 in payments from pharmaceutical and medical device companies, with $385.85 received in 2024. These payments were reported across 40 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($877.36).
As a Medicare-enrolled provider, Sanchez has provided services to 19,476 Medicare beneficiaries, totaling 54,276 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location South Miami, FL
- Active Since 05/26/2014
- Last Updated 06/04/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508278532
Products in Payments
- Enhertu (Drug) $239.02
- KEYTRUDA (Biological) $156.06
- JAKAFI (Drug) $152.66
- PLUVICTO (Drug) $104.26
- clonoSEQ (Device) $43.40
- DARZALEX (Biological) $24.65
- LUTATHERA (Drug) $21.59
- Doptelet (Drug) $20.64
- Lenvima (Drug) $17.51
- ICLUSIG (Drug) $16.72
- Orserdu (Drug) $14.46
- OMNIGRAFT (Device) $11.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in South Miami
Dr. Eddie Armas, Md, MD
General Practice — Payments: $1.3M
General Practice $1.3M
Dr. Alvaro Ordonez, Dds, DDS
General Practice — Payments: $7,157
General Practice $7,157
Dr. Arnaldo Lopez, Dds, DDS
General Practice — Payments: $1,790
General Practice $1,790
Dr. Marco Leyte-Vidal, Dmd, DMD
General Practice — Payments: $1,663
General Practice $1,663
Dr. Jose Rodriguez, Dds, DDS
General Practice — Payments: $1,158
General Practice $1,158
Dr. Joaquin Novoa
General Practice — Payments: $985.82
General Practice $985.82